SER vs VMC · rev $56.0K vs P/E 35, rev $7.42B
Serina Therapeutics Inc (SER) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
SER currently screens at market cap $29.7M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the SER and VMC stock pages for the full models.
Not investment advice.